UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study

Osteoarthritis and cartilage, 2017-10, Vol.25 (10), p.1598-1606

2017

Volltextzugriff (PDF)

Treating rheumatoid arthritis to target: recommendations of an international task force

Annals of the Rheumatic Diseases, 2010-04, Vol.69 (4), p.631-637

2010

Volltextzugriff (PDF)

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011

Annals of the rheumatic diseases, 2012-04, Vol.71 (Suppl 2), p.i2-i45

2012

Volltextzugriff (PDF)

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009

Annals of the rheumatic diseases, 2010-01, Vol.69 (Suppl 1), p.i2-i29

2010

Volltextzugriff (PDF)

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Annals of the rheumatic diseases, 2011-03, Vol.70 (Suppl 1), p.i2-i36

2011

Volltextzugriff (PDF)

Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone

Scandinavian journal of rheumatology, 2015-09, Vol.44 (5), p.354-358

2015

Volltextzugriff (PDF)

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008

Annals of the rheumatic diseases, 2008-12, Vol.67 (Suppl 3), p.iii2-iii25

2008

Volltextzugriff (PDF)

Outcome measures in placebo-controlled trials of osteoarthritis: responsiveness to treatment effects in the REPORT database

Osteoarthritis and cartilage, 2011-05, Vol.19 (5), p.483-492

2011

Volltextzugriff (PDF)

Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)

Annals of the rheumatic diseases, 2003-11, Vol.62 (suppl 2), p.ii2-ii9

2003

Volltextzugriff (PDF)

A Phase 2 Study Evaluating the Efficacy and Safety of a Novel, Proprietary, Nano-Formulated, Lower Dose Oral Diclofenac

Pain medicine (Malden, Mass.), 2012-11, Vol.13 (11), p.1491-1498

2012

Volltextzugriff (PDF)

The times they are a changin

Rheumatology (Oxford, England), 2013-01, Vol.52 (1), p.3-4

2013

Volltextzugriff (PDF)

Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study

Current medical research and opinion, 2014-09, Vol.30 (9), p.1883-1893

2014

Volltextzugriff (PDF)

Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity

Clinical rheumatology, 2014-07, Vol.33 (7), p.893-901

2014

Volltextzugriff (PDF)

Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study

Clinical rheumatology, 2018-09, Vol.37 (9), p.2331-2340

2018

Volltextzugriff (PDF)

Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial

Clinical rheumatology, 2017-06, Vol.36 (6), p.1357-1367

2017

Volltextzugriff (PDF)

Rheumatic fever. The relationships between host, microbe, and genetics

Rheumatic diseases clinics of North America, 1998-05, Vol.24 (2), p.237-259

1998

Volltextzugriff (PDF)

Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice

Journal of rheumatology, 2000-06, Vol.27 (6), p.1338

2000

Volltextzugriff (PDF)

Lower-Dose Diclofenac Submicron Particle Capsules Provide Early and Sustained Acute Patient Pain Relief in a Phase 3 Study

Postgraduate medicine, 2013-09, Vol.125 (5), p.130-138

2013

Volltextzugriff (PDF)

Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2)

Clinical and experimental rheumatology, 2015-05, Vol.33 (3), p.297

2015

Volltextzugriff (PDF)

Silicone gel filled breast implants and connective tissue disease: an overview

Journal of rheumatology, 1994-02, Vol.21 (2), p.239

1994

Volltextzugriff (PDF)

Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases

Journal of hypertension. Supplement, 2002-09, Vol.20 (6), p.S25

Gibofsky, Allan

2002

Volltextzugriff (PDF)

An analysis of recent antitrust issues affecting specialty practice: is dermatology immune?

Seminars in cutaneous medicine and surgery, 2005-09, Vol.24 (3), p.137-143

Gibofsky, Allan

2005

Volltextzugriff (PDF)

Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study

Postgraduate medicine, 2015-09, Vol.127 (5), p.517-528

2015

Volltextzugriff (PDF)

Rheumatic fever and poststreptococcal reactive arthritis

Current opinion in rheumatology, 1995-07, Vol.7 (4), p.299-306

1995

Volltextzugriff (PDF)

The genetics of rheumatic fever: relationship to streptococcal infection and autoimmune disease

Journal of rheumatology. Supplement, 1991-08, Vol.30, p.1

1991

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(123)

Sprache

Englisch
(123)

Erscheinungsjahr

n.n

Thema

Humans
(121)
Science & Technology
(95)
Life Sciences & Biomedicine
(93)
Rheumatology
(51)
Female
(44)
Male
(39)
Adult
(29)
Middle Aged
(28)
Arthritis, Rheumatoid - Drug Therapy
(24)
United States
(22)
Antirheumatic Agents - Therapeutic Use
(21)
Biological And Medical Sciences
(21)
General & Internal Medicine
(20)
Medical Sciences
(20)
Medicine, General & Internal
(20)
Aged
(19)
Rheumatoid Arthritis
(19)
Treatment Outcome
(18)
Osteoarthritis
(13)
Diseases Of The Osteoarticular System
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study

Treating rheumatoid arthritis to target: recommendations of an international task force

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008

Outcome measures in placebo-controlled trials of osteoarthritis: responsiveness to treatment effects in the REPORT database

Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)

A Phase 2 Study Evaluating the Efficacy and Safety of a Novel, Proprietary, Nano-Formulated, Lower Dose Oral Diclofenac

The times they are a changin

Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study

Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity

Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study

Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial

Rheumatic fever. The relationships between host, microbe, and genetics

Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice

Lower-Dose Diclofenac Submicron Particle Capsules Provide Early and Sustained Acute Patient Pain Relief in a Phase 3 Study

Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2)

Silicone gel filled breast implants and connective tissue disease: an overview

Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases

An analysis of recent antitrust issues affecting specialty practice: is dermatology immune?

Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study

Rheumatic fever and poststreptococcal reactive arthritis

The genetics of rheumatic fever: relationship to streptococcal infection and autoimmune disease

Aktive Filter

Suchergebnisse filtern